Company Metrics

• 0 P/E
• 1.15 P/S
• 1.3 P/B
• -0.474 EPS
• 14.17% Cash ROIC
• 0.51 Cash Ratio
• 0 / 0% Dividend
• 193,698.00 Avg. Vol.
• 60.57M Shares
• 170.7M Market Cap.

Company Description

Solta Medical, Inc. designs, develops, manufactures, and markets energy-based medical device systems for aesthetic applications. Its products include Thermage NXT and CPT systems that provide non-invasive treatment options for skin tightening and contouring, body shaping, and enhancement in the appearance of cellulite; Fraxel re:fine and Fraxel re:store systems, which offer treatments for skin conditions, such as fine lines and pigmentation; and Fraxel re:pair system for dermatological procedures requiring ablation, coagulation, and resurfacing of soft tissue, as well as for rhytides, pigmentation, and vascular dyschromia. The company's Fraxel re:store system also offers treatments for acne and surgical scars, deeper lines and wrinkles, and actinic keratoses. Its systems consist of one or more hand pieces, a console that incorporates a graphical user interface, an energy source and electronics, and a disposable treatment tip. The company's customers include dermatologists, plastic surgeons, general and family practitioners, gynecologists, and ophthalmologists. Solta Medical markets its systems and treatment tips through direct sales force and a network of distributors in the United States and internationally. The company was formerly known as Thermage, Inc. and changed its name to Solta Medical, Inc. in December 2008. The company was founded in 1995 and is headquartered in Hayward, California.
less

Solta Medical, Inc. designs, develops, manufactures, and markets energy-based medical device systems for aesthetic applications. Its products include Thermage NXT and CPT systems that provide non-invasive treatment options for skin tightening and contouring, body shaping, and enhancement in the appearance of cellulite; Fraxel re:fine and Fraxel re:store systems, which offer treatments for skin con...
more

News